Article Sidebar

Download
Download Article

Main Article Content

Abstract

Hypertensive Disorders in Pregnancy (HDP) remain a major contributor to maternal morbidity and mortality worldwide. This study aimed to analyze the characteristics of pregnant women with HDP at Prof. Dr. Soekandar Hospital, Mojokerto Regency, from January to June 2026, with particular attention to Diabetes Mellitus (DM) comorbidity. A retrospective descriptive observational study was conducted using medical records of 760 pregnant women. Total sampling was applied to all patients diagnosed with HDP. Data were analyzed descriptively based on age, parity, obesity status, and complications among patients with DM. A total of 191 HDP cases were identified, representing a prevalence of 25.13%, with the highest number recorded in May (37 cases). Most patients were aged 20–34 years (51.8%), followed by those aged >35 years (37.7%). Multigravida women predominated, accounting for 126 cases (66%), while obesity was identified in 116 cases (60.7%). Among 33 patients with DM, 25 (75.7%) progressed to severe preeclampsia. The findings indicate a relatively high prevalence of HDP, with reproductive-age, multigravida, and obese women comprising the majority of cases. The high proportion of patients with DM progressing to severe preeclampsia highlights the importance of glycemic screening and metabolic management as integral components of antenatal care.

Keywords

Hypertensive Disorders in Pregnancy Preeclampsia Multigravida Obesity Diabetes Mellitus

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

How to Cite
Wardhani, M. K. (2026). Characteristics of Pregnant Women with Hypertension During Pregnancy at Prof. Dr. Soekandar Hospital from January to June 2026: A Focus on Diabetes Mellitus Comorbidities. Golden Ratio of Mapping Idea and Literature Format, 6(4), 13–24. https://doi.org/10.52970/grmilf.v6i4.2610
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. American College of Obstetricians and Gynecologists. (2020). Gestational hypertension and preeclampsia: ACOG Practice Bulletin No. 222. Obstetrics & Gynecology, 135(6), e237–e260.
  2. American Diabetes Association. (2024). Management of diabetes in pregnancy: Standards of care in diabetes—2024. Diabetes Care, 47(Supplement 1), S282–S294.
  3. Bartsch, E., Medcalf, K. E., Park, A. L., Ray, J. G., & High Risk of Pre-eclampsia Clinical Indicators Group. (2016). Clinical risk factors for pre-eclampsia determined in early pregnancy: Systematic review and meta-analysis of large cohort studies. BMJ, 353, i1753.
  4. Bellamy, L., Casas, J. P., Hingorani, A. D., & Williams, D. J. (2007). Pre-eclampsia and risk of cardiovascular disease and cancer in later life: Systematic review and meta-analysis. BMJ, 335(7627), 974.
  5. Catalano, P. M. (2010). Obesity, insulin resistance, and pregnancy outcome. Reproduction, 140(3), 365–371.
  6. Cunningham, F. G., Leveno, K. J., Bloom, S. L., Dashe, J. S., Hoffman, B. L., Casey, B. M., & Spong, C. Y. (2022). Williams obstetrics (26th ed.). McGraw Hill Education.
  7. Duley, L. (2009). The global impact of pre-eclampsia and eclampsia. Seminars in Perinatology, 33(3), 130–137.
  8. Huda, S. S., Freeman, D. J., & Nelson, S. M. (2009). Obesity in pregnancy. Clinical Reviews in Bone and Mineral Metabolism, 7(1), 58–69.
  9. Kementerian Kesehatan Republik Indonesia. (2021). Profil kesehatan Indonesia tahun 2020. Kementerian Kesehatan Republik Indonesia.
  10. Metzger, B. E., Lowe, L. P., Dyer, A. R., Trimble, E. R., Chaovarindr, U., Coustan, D. R., Hadden, D. R., McCance, D. R., Hod, M., McIntyre, H. D., Oats, J. J., Persson, B., Rogers, M. S., & Sacks, D. A. (2008). Hyperglycemia and adverse pregnancy outcomes. New England Journal of Medicine, 358(19), 1991–2002.
  11. Poon, L. C., Shennan, A., Hyett, J. A., Kapur, A., Hadar, E., Divakar, H., McAuliffe, F., da Silva Costa, F., von Dadelszen, P., McIntyre, H. D., & Hod, M. (2019). The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. International Journal of Gynecology & Obstetrics, 145(Supplement 1), 1–33.
  12. Rana, S., Lemoine, E., Granger, J. P., & Karumanchi, S. A. (2019). Preeclampsia: Pathophysiology, challenges, and perspectives. Circulation Research, 124(7), 1094–1112.
  13. Roberts, J. M., & Escudero, C. (2012). The placenta in preeclampsia. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health, 2(2), 72–83.
  14. Say, L., Chou, D., Gemmill, A., Tunçalp, Ö., Moller, A. B., Daniels, J., Gülmezoglu, A. M., Temmerman, M., & Alkema, L. (2014). Global causes of maternal death: A WHO systematic analysis. The Lancet Global Health, 2(6), e323–e333.
  15. Sibai, B. M. (2002). Chronic hypertension in pregnancy. Obstetrics & Gynecology, 100(2), 369–377.
  16. Steegers, E. A., von Dadelszen, P., Duvekot, J. J., & Pijnenborg, R. (2010). Pre-eclampsia. The Lancet, 376(9741), 631–644.
  17. World Health Organization. (2011). WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. World Health Organization.